[PTGX] YoY Quarter Result on 30-Sep-2022 [#Q3]

Stock
[PTGX] Protagonist Therapeutics, Inc.
Announcement Date
08-Nov-2022
Financial Year
2022
Quarter
30-Sep-2022 [#Q3]
Profit Trend
QoQ- 25.77%
YoY- 10.78%
Quarter Report
PTGX's Result
PTGX's Financial Summary
View:
Show?
Quarter Result
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
Revenue 4,675 0 0 10,286 13,114 4,141 6,117 -4.37%
PBT -33,630 -34,105 -31,232 -33,804 -7,763 -16,511 -8,735 25.16%
Tax -420 -827 -1,071 122 -40 -102 0 -
NP -33,210 -34,105 -30,161 -33,804 -7,763 -16,409 -8,735 24.90%
Tax Rate - - - - - - - -
Total Cost 37,885 34,105 30,161 44,090 20,877 20,550 14,852 16.87%
Ratio Analysis
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
NP Margin -710.37 0.00 0.00 -328.64 -59.20 -396.26 -142.80 30.62%
Per Share
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
EPS -0.54 -0.58 -0.62 -0.70 -0.21 -0.61 -0.38 6.02%
EPS Diluted -0.54 -0.58 -0.61 -0.70 -0.21 -0.61 -0.38 6.02%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.